Myocardial infarction due to nonbacterial thrombotic endocarditis in a patient with advanced bladder cancer
Cardiovascular Intervention and Therapeutics · 2026-07 · 41 (3) · 833-834
DOI: 10.1007/s12928-026-01256-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Intervention and Therapeutics, online erschienen am 31.03.2026. Verfasst von Hirofumi Kusumoto und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Osaka Medical and Pharmaceutical University Hospital, Osaka, Japan. hirofumi.kusumoto@ompu.ac.jp. Die Arbeit nennt 2 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Cardiology, Osaka Medical and Pharmaceutical University Hospital, Osaka, Japan. hirofumi.kusumoto@ompu.ac.jp.
- Department of Cardiology, Osaka Medical and Pharmaceutical University Hospital, Osaka, Japan.
- Department of Cardiology, Osaka Medical and Pharmaceutical University Hospital, Osaka, Japan. hideaki.morita@ompu.ac.jp.
Zitieren
APA
Kusumoto, H., Inoue, M., Shishikura, D., Kanzaki, Y., Harada-Shiba, M., & Morita, H. (2026). Myocardial infarction due to nonbacterial thrombotic endocarditis in a patient with advanced bladder cancer. Cardiovascular Intervention and Therapeutics, 41(3), 833-834. https://doi.org/10.1007/s12928-026-01256-4
Vancouver
Kusumoto H, Inoue M, Shishikura D, Kanzaki Y, Harada-Shiba M, Morita H. Myocardial infarction due to nonbacterial thrombotic endocarditis in a patient with advanced bladder cancer. Cardiovascular Intervention and Therapeutics. 2026;41(3):833-834. doi:10.1007/s12928-026-01256-4
BibTeX
@article{Kusumoto2026,
author = {Kusumoto, Hirofumi and Inoue, Masanao and Shishikura, Daisuke and Kanzaki, Yumiko and Harada-Shiba, Mariko and Morita, Hideaki},
title = {Myocardial infarction due to nonbacterial thrombotic endocarditis in a patient with advanced bladder cancer},
journal = {Cardiovascular Intervention and Therapeutics},
year = {2026},
volume = {41},
number = {3},
pages = {833--834},
doi = {10.1007/s12928-026-01256-4}
}
EUVIMED